We were told this when Roche tried the hostile takeover at $60.
They just need better sample prep to automate and standardize sample processing which is still a huge source of variability in the experiments I have seen/performed.
Sentiment: Strong Buy
Just need a $750 stock price on ILMN and this company will really be another AAPL.
patience, lemonteeth. AAPL didn't go to $750 overnight. NextSeq 500 is a incredible instrument and the HiSeq x 10 are gonna pretty much drive adoption of population and cancer studies. just buy and hold. It's AAPL in 2009